Related references
Note: Only part of the references are listed.BAP1-deficient tumor/nevus with germline aberration: A potential pitfall in assessing melanocytic neoplasms with single nucleotide polymorphism array
Amin A. Hedayat et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2019)
BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas
Matthew G. Field et al.
CLINICAL CANCER RESEARCH (2019)
Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma
Samantha Sarcognato et al.
VIRCHOWS ARCHIV (2019)
Exome analysis of carotid body tumor
Anastasiya V. Snezhkina et al.
BMC MEDICAL GENOMICS (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma
Richard E. Watchorn et al.
PEDIATRIC DERMATOLOGY (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
Sebastian Walpole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma
K. G. Ewens et al.
BMC CANCER (2018)
Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer
Takashi Hirosawa et al.
PLOS ONE (2018)
Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma
Neil Farquhar et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas
Ganesh M. Shankar et al.
NEURO-ONCOLOGY (2017)
Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer
Xiang-Yu Wang et al.
TUMOR BIOLOGY (2017)
Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma
Hao Song et al.
ONCOTARGET (2017)
Molecular markers of paragangliomas/pheochromocytomas
Svetlana O. Zhikrivetskaya et al.
ONCOTARGET (2017)
A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1
Yu-Zheng Ge et al.
JOURNAL OF CANCER (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing
Beryl Royer-Bertrand et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma
Johannes A.P. van de Nes et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations
Yuwaraj Kadariya et al.
CANCER RESEARCH (2016)
Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era
Suja Pillai et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Different Prognostic Roles of Tumor Suppressor Gene BAP1 in Cancer: A Systematic Review with Meta-Analysis
Claudio Luchini et al.
GENES CHROMOSOMES & CANCER (2016)
Mesothelioma families without inheritance of a BAP1 predisposing mutation
Valeria Ascoli et al.
CANCER GENETICS (2016)
BAP1 suppresses lung cancer progression and is inhibited by miR-31
Mengchao Yu et al.
ONCOTARGET (2016)
Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis
Joakim Crona et al.
CLINICAL CANCER RESEARCH (2015)
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Masaki Nasu et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
Marta Cigognetti et al.
MODERN PATHOLOGY (2015)
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
Luis Jaime Castro-Vega et al.
NATURE COMMUNICATIONS (2015)
DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients
Erica S. S. de Araujo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma
Anna E. Koopmans et al.
MODERN PATHOLOGY (2014)
Autodeubiquitination Protects the Tumor Suppressor BAP1 from Cytoplasmic Sequestration Mediated by the Atypical Ubiquitin Ligase UBE2O
Nazar Mashtalir et al.
MOLECULAR CELL (2014)
Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC
Ilsiya Ibragimova et al.
EPIGENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma
Akeesha A. Shah et al.
PATHOLOGY (2013)
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Michele Carbone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma
Karin Wadt et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Emerging Anatomy of the BAP1 Tumor Suppressor System
Anne E. White et al.
SCIENCE (2012)
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
Mohamed H. Abdel-Rahman et al.
JOURNAL OF MEDICAL GENETICS (2011)
Germline mutations in BAP1 predispose to melanocytic tumors
Thomas Wiesner et al.
NATURE GENETICS (2011)
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa et al.
NATURE GENETICS (2011)
Share Paper
